反応式
[CH:1]1([C:4]2[CH:12]=[C:11]([C:13]([F:16])([F:15])[F:14])[CH:10]=[CH:9][C:5]=2[C:6]([OH:8])=O)[CH2:3][CH2:2]1.C(N(CC)C(C)C)(C)C.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2N=CC=CC=2N=N1.Cl.Cl.[N:52]1([CH:57]2[CH2:62][CH2:61][O:60][CH2:59][CH:58]2[NH2:63])[CH2:56][CH2:55][CH2:54][CH2:53]1>CN(C)C=O>[CH:1]1([C:4]2[CH:12]=[C:11]([C:13]([F:16])([F:15])[F:14])[CH:10]=[CH:9][C:5]=2[C:6]([NH:63][CH:58]2[CH:57]([N:52]3[CH2:53][CH2:54][CH2:55][CH2:56]3)[CH2:62][CH2:61][O:60][CH2:59]2)=[O:8])[CH2:2][CH2:3]1参加物
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
2-Cyclopropyl-4-trifluoromethyl-benzoic acid (intermediate J, 118 mg, 0.513 mmol) was dissolved in 2.5 mL dimethylformamide. N,N-Diisopropyl ethyl amine (338 mg, 2.62 mmol) and O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (195 mg, 0.513 mmol) were added. After 10 minutes of stirring at room temperature trans-(4-pyrrolidin-1-yl-tetrahydro-pyran-3-ylamine dihydrochloride (intermediate 1,187 mg, 0.769 mmol) was added. The reaction mixture was stirred at room temperature overnight. The solvent was evaporated off. The residue was taken up in 2N sodium carbonate solution and ethyl acetate and was extracted three times with ethyl acetate. The combined organic phases were dried on sodium sulfate, filtered and evaporated. Purification of the residue by flash chromatography on silica gel (heptane/ethyl acetate/triethylamine 1:0:0→10:10:1) yielded the title compound as a white solid (121 mg, 62%), MS: m/e=383.3 [(M+H)+].
後処理
- additionwas added
- customThe solvent was evaporated off
- extractionethyl acetate and was extracted three times with ethyl acetate
- customThe combined organic phases were dried on sodium sulfate
- filtrationfiltered
- customevaporated
- customPurification of the residue by flash chromatography on silica gel (heptane/ethyl acetate/triethylamine 1:0:0→10:10:1)
出典と根拠
- ORDレコード
- ord-fac9c8face704ca2b24997f1ae65abf9
- 出典データセット
- uspto-grants-2013_09
- 特許番号
- US08524909B2
関連ノート
読み込み中…